Reactive species-mediated regulation of cell signaling and the cell cycle: The role of MAPK

Antioxidants and Redox Signaling

Volumn 7, Issue 5-6, 2005, Pages 726-740

  Cakir, Yavuz ^a   Ballinger, Scott W ^a,b  

^a University of Alabama at Birmingham   (United States)

^b VH G019 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; NITROGEN OXIDE; PHOSPHATASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

APOPTOSIS; CARDIOVASCULAR DISEASE; CELL CYCLE; CELL DAMAGE; CELL DEATH; CELL GROWTH; CELL INTERACTION; CONCENTRATION RESPONSE; CONTROL SYSTEM; ENZYME ACTIVATION; ENZYME INACTIVATION; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL CYCLE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 17644405804     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.726     Document Type: Review

References (120)

1. Abid MR, Tsai JC, Spokes KC, Deshpande SS, Irani K, and Aird WC. Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism. FASEB J 15: 2548-2550, 2001.
2. Adams JM and Cory S. Apoptosomes: engines for caspase activation. Curr Opin Cell Biol 14: 715-720, 2002.
3. Antonsson B, Montessuit S, Lauper S, Eskes R, and Martino JC. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 345: 271-278, 2000.
4. - in vascular smooth muscle cells. Circ Res 77: 29-36, 1995.
5. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, and Rhee SG. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217-221, 1997.
6. Ballinger SW, Patterson WC, Yan C-N, Doan R, Burow DL, Young CG, Yakes FM, Van Houten B, Ballinger CA, Freeman BA, and Runge MS. Hydrogen peroxide and peroxynitrite induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 86: 960-966, 2000.
7. Ballinger SW, Patterson WC, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, Reuf J, Horaist C, Lebovitz RM, Hunter G, McIntyre K, and Runge MS. Mitochondrial integrity and function in atherogenesis. Circulation 106: 544-549, 2002.
8. Barford D. Protein phosphatases. Curr Opin Struct Biol 5: 728-734, 1995.
9. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, and Runge MS. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 108: 1513-1522, 2001.
10. Behr D, Rupin A, Fabiani JN, and Verbeuren TJ. Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis 142: 335-344, 1999.
11. Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby EC, and Evan GI. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest 93: 820-828, 1994.
12. Blake RA, Walker TR, and Watson SP. Activation of human platelets by peroxovanadate is associated with tyrosine phosphorylation of phospholipase C gamma and formation of inositol phosphates. Biochem J 290: 471-475, 1993.
13. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39: 615-647, 2003.
14. Bratton SB, MacFarlane M, Cain K, and Cohen GM. Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp Cell Res 256: 27-33, 2000.
15. Brookes PS, Zhang J, Dai L, Zhou F, Parks DA, Darley-Usmar VM, and Anderson PG. Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy. J Mol Cell Cardiol 33: 69-82, 2001.
16. Buchwalow IB, Podzuweit T, Bocker W, Samoilova VE, Thomas S, Wellner M, Baba HA, Robenek H, Schnekenburger J, and Lerch MM. Vascular smooth muscle and nitric oxide synthase. FASEB J 16: 500-508, 2002.
17. Cai J and Jones DP. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 273: 11401-11404, 1998.
18. Cassina A and Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 328: 309-316, 1996.
19. Chang L and Karin M. Mammalian MAP kinase signalling cascades. Nature 410: 37-41, 2001.
20. Chen K, Vita JA, Berk BC, and Keaney JF Jr. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves Src-dependent epidermal growth factor receptor transactivation. J Biol Chem 276: 16045-16050, 2001.
21. Chen Z, Siu B, Ho Y-S, Vincent R, Chua CC, Hamdy RC, and Chua BH. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol 30: 2281-2289, 1998.
22. Coats S, Flanagan WM, Nourse J, and Roberts JM. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272: 877-880, 1996.
23. Corral-Debrinski M, Stepien G, Shoffner JM, Lott MT, Kanter K, and Wallace DC. Hypoxemia is associated with mitochondrial DNA damage and gene induction: implications for cardiac disease. JAMA 266: 1812-1816, 1991.
24. Denault JB and Salvesen GS. Caspases: keys in the ignition of cell death. Chem Rev 102: 4489-4500, 2002.
25. Denu JM and Tanner KG. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37: 5633-5642, 1998.
26. Deora AA, Win T, Vanhaesebroeck B, and Lander HM. A redox-triggered Ras-effector interaction. Recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress. J Biol Chem 273: 29923-29928, 1998.
27. Deshpande NN, Sorescu D, Seshiah P, Ushio-Fukai M, Akers M, Yin Q, and Griendling KK. Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. Antioxid Redox Signal 4: 845-854, 2002.
28. Dhaunsi GS, Matthews C, Kaur K, and Hassid A. NO increases protein tyrosine phosphatase activity in smooth muscle cells: relationship to antimitogenesis. Am J Physiol 212: H1342-H1349, 1997.
29. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, and Weinberg RA. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73: 499-511, 1993.
30. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
31. Duan J and Karmazyn M. Relationship between oxidative phosphorylation and adenine nucleotide translocase activity in two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion. Can J Physiol Pharmacol 67: 704-709, 1989.
32. Earnshaw WC, Martins LM, and Kaufmann SF. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383-424, 1999.
33. Forman HJ, Boveris A, and Prior WA (Eds). Free radicals in Biology. Orlando, FL: Academic Press, 1982, p. 65.
34. Garg UC and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
35. Giulivi C, Poderoso JJ, and Boveris A. Production of nitric oxide by mitochondria. J Biol Chem 273: 11038-11043, 1998.
36. 2-terminal kinase. Am J Physiol 277 (4 Pt 2): H1647-H1653, 1999.
37. Griendling K, Minieri C, Ollerenshaw J, and Alexander RW Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 14: 1141-1148, 1994.
38. Gupta S, Campbell D, Derijard B, and Davis RJ. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267: 389-393, 1995.
39. 2. J Biol Chem 271: 4138-4142, 1996.
40. Guzik TJ, Nick EJ, West NE, Pillai R, Taggart DP, and Channon KM. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension 39: 1088-1094, 2002.
41. Hazen SL and Henecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 99: 2075-2081, 1997.
42. He T, Weintraub NL, Goswami PC, Chatterjee P, Flaherty DM, Domann FE, and Oberley LW. Redox factor-1 contributes to the regulation of progression from G0/G1 to S by PDGF in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 285: H804-H812, 2003.
43. Heitzer T, Schlinzig T, Krohn K, Meinertz T, and Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104: 2673-2678, 2001.
44. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A 94: 3633-3638, 1997.
45. Hsich E, Segal BH, Pagano PJ, Rey FE, Paigen B, Deleonardis J, Hoyt RF, Holland SM, and Finkel T. Vascular effects following homozygous disruption of p47(phox): an essential component of NADP oxidase. Circulation 101: 1234-1236, 2000.
46. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, and Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
47. Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80: 225-236, 1995.
48. Ide T, Tsutsui H, Kinugawa S, Suematsu N, Hayashidani S, Ichikawa K, Utsumi H, Machida Y, Egashira K, and Takeshita A. Direct evidence for increased hydroxyl radicals orginating from superoxide in the failing myocardium. Circ Res 86: 152-157, 2000.
49. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 356: 1-11, 1998.
50. Ishida A, Sasaguri T, Kosaka C, Nojima H, and Ogata J. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells. J Biol Chem 272: 10050-10057, 1997.
51. Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, and Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci U S A 93: 11848-11852, 1996.
52. Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ, and Jones OT. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 271: H1626-H1634, 1996.
53. Jordan JD, Landau EM, and Iyengar R. Signaling networks: the origins of cellular multitasking. Cell 103: 193-200, 2000.
54. Kakolyris S, Kaklamanis L, Hickson ID, and Harris AL. Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease. Histopathology 33: 561-569, 1998.
55. Kaur K, Yao J, Pan X, Matthews C, and Hassid A. NO decreases phosphorylation of focal adhesion proteins via reduction of Ca in rat aortic smooth muscle cells. Am J Physiol 274: H1613-Hl619, 1998.
56. Kim SM, Byun JS, Jung YD, Kang IC, Choi SY, and Lee KY. The effects of oxygen radicals on the activity of nitric oxide synthase and guanylate cyclase. Exp Mol Med 30: 221-226, 1998.
57. Kim YM, Chung HT, Kim SS, Han JA, Yoo YM, Kim KM, Lee GH, Yun HY, Green A, Li J, Simmons RL, and Billiar TR. Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J Neurosci 19: 6740-6747, 1999.
58. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, and Le Boeuf RC. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20: 1529-1535, 2000.
59. Kirlin WG, Cai J, Thompson SA, Daiaz D, Kavanagh TJ, and Jones DP. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med 27: 1208-1218, 1999.
60. Knight-Lozano CA, Young CG, Burow DL, Hu Z, Uyeminami D, Pinkerton K, Ischiropoulos H, and Ballinger SW. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 105: 849-854, 2002.
61. Koglin J, Glysing-Jensen T, Mudgett JS, and Russell ME. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation 97: 2059-2065, 1998.
62. Kumagai A and Dunphy WG. The Cdc25 protein controls tyrosine dephosphorylation of the Cdc2 protein in a cell free system. Cell 64: 903-914, 1991.
63. Lander HM, Ogiste JS, Pearce SF, Levi R, and Novogrodsky A. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J Biol Chem 270: 7017-7020, 1995.
64. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.
65. Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T, Yu ZX, Ferrans VJ, Howard BH, and Finkel T. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 274: 7936-7940, 1999.
66. Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Oh-ishi S, Steinbrecher UP, and Heinecke JW. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 272: 1433-1436, 1997.
67. Lepoivre M, Fieschi F, Coves J, Thelander L, and Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochem Biophys Res Commun 179: 442-448, 1991.
68. Lew DJ and Kornbluth S. Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Curr Opin Cell Biol 8: 795-804, 1996.
69. Li AE, Ito H, Rovira II, Kim KS, Takeda K, Yu ZY, Ferrans VJ, and Finklel T. A role for reactive oxygen species in endothelial cell anoikis. Circ Res 85: 304-310, 1999.
70. Li J, Billiar TR, Talanian RV, and Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via 5-nitrosylation. Biochem Biophys Res Commun 240: 419-424, 1997.
71. Liao DF, Jin ZG, Baas AS, Daum G, Gygi SP, Aebersold R, and Berk BC. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem 275: 189-196, 2000.
72. Liu X, Kim CN, Yang J, Jemmerson R, and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157, 1996.
73. Luoma JS and Ylä-Herttuala S. Expression of inducible nitric oxide synthase in macrophages and smooth muscle cells in various types of human atherosclerotic lesions. Virchows Arch 434: 561-568, 1999.
74. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650, 1995.
75. MacMillan-Crow LA, Crow JP, and Thompson JA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 37: 1613-1622, 1998.
76. Manna SK. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem 273: 13245-13254, 1998.
77. Marumo T, Schini-Kerth VB, Fisslthaler B, and Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96: 2361-2367, 1997.
78. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, Jo H, and Harrison DG. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 285: H2290-H2297, 2003.
79. Meier P, Finch A, and Evan G. Apoptosis in development. Nature 407: 796-801, 2000.
80. Meng TC, Fukada T, and Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9: 387-399, 2002.
81. Michael JR, Markewitz BA, and Kohan DE. Oxidant stress regulates basal endothelin-1 production by cultured rat pulmonary endothelial cells. Am J Physiol 273: L768-L774, 1997.
82. Migliaccio E, Gorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, and Pelicci PG. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402: 309-313, 1999.
83. Nemoto S and Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295: 2450-2452.
84. Packer MA, Porteous CM, and Murphy MP. Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite. Biochem Mol Biol 40: 527-534, 1996.
85. Parks DA, Williams TK, and Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol 254: G768-G774, 1988.
86. Podrez EA, Abu-Soud HM, and Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28: 1717-1725, 2000.
87. Rao GN. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases. Oncogene 13: 713-719, 1996.
88. Rao GN and Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70: 593-599, 1992.
89. Ravid T, Sweeney C, Gee P, Carraway KL 3rd, and Goldkorn T. Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation. J Biol Chem 277: 31214-31219, 2002.
90. Ross R. Mechanisms of disease: atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999.
91. Rudic RD, Shesely EG, Meada N, Smithies O, Segal SS, and Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101: 731-736, 1998.
92. Sarkar R, Gordon D, Stanley JC, and Webb RC. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Am J Physiol 272: H1810-H1818, 1997.
93. Sattler M, Winkler T, Verma S, Byrne CH, Shrikhande G, Salgia R, and Griffin JD. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 93: 2928-2935, 1999.
94. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, and Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 267: 5317-5323, 1992.
95. Seger R and Krebs EG. The MAPK signaling cascade. FASEB J 9: 726-735, 1995.
96. Shaulian E and Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131-E136, 2002.
97. Sherr CJ. Cancer cell cycles. Science 274: 1672-1677, 1996.
98. Sherr CJ and Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995.
99. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, and Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265: 391-394, 1994.
100. Su B, Mitra S, Gregg H, Flavahan S, Chotani MA, Clark KR, Goldschmidt-Clermont PJ, and Flavahan NA. Redox regulation of vascular smooth muscle cell differentiation. Circ Res 89: 39-46, 2001.
101. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
102. Suzuki HJF and Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 22: 269-285, 1997.
103. Sventek P, Turgeon A, and Schiffrin EL. Vascular endothelin-1 gene expression and effect on blood pressure of chronic ETA endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats. Circulation 95: 240-244, 1997.
104. Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, and Takeshita A. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 99: 278-287, 1997.
105. Tan S, Gelman S, Wheat JK, and Parks DA. Circulating xanthine oxidase in human ischemia reperfusion. South Med J 88: 479-82, 1995.
106. Thomas JA, Poland B, and Honzatko R. Protein sulfhydryls and their role in the antioxidant function of protein 5-thiolation. Arch Biochem Biophys 319: 1-9, 1995.
107. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, and Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90: 1205-1213, 2002.
108. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 552: 335-344, 2003.
109. Tzeng E, Kim YM, Pitt BR, Lizonova A, Kovesdi I, and Billiar TR. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery 122: 255-263, 1997.
110. Ushio-Fukai M, Alexander RW, Akers M, and Griendling KK. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273: 15022-15029, 1998.
111. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, and Alexander RW. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 489-495, 2001.
112. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, and Vaux DL. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43-53, 2000.
113. Wang D, Yu X, and Brecher P. Nitric oxide and N-acetyl-cysteine inhibit the activation of mitogen-activated protein kinases by angiotensin II in rat cardiac fibroblasts. J Biol Chem 273: 33027-33034, 1998.
114. White CR, Darley-Usmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, Parks DA, Tarpey MM, and Freeman BA. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci U S A 93: 8745-8749, 1996.
115. Yakes FM and Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A 94: 514-519, 1997.
116. Yan L-J and Sohal RS. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc Natl Acad Sci U S A 95: 12896-12901, 1998.
117. Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, and Nabel EG. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci U S A 93: 7905-7910, 1996.
118. Zhang H, Hannon GJ, and Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750-1758, 1994.
119. Zhang Y, Marcillat O, Giulivi C, Ernster L, and Davies KJ. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 265: 16330-16336, 1990.
120. Zhang Z, Blake DR, Stevens CR, Kanczler JM, Winyard PG, and Symons MC. A reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: the role of NADH as an electron donor. Free Radic Res 28: 151-164, 1998.